Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Incyte Corporation

NDC labeler codes: 50881, 73535

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

21Products (NDC)

Prescription medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
May 1, 2026NDA217180 Ruxolitinib
JAKAFI XR
Incyte Corp
August 14, 2024BLA761411 Axatilimab-csfr
NIKTIMVO
Incyte Corp
March 22, 2023BLA761334 Retifanlimab-dlwr
ZYNYZ
Incyte Corp
September 21, 2021NDA215309 Ruxolitinib
OPZELURA
Incyte Corp
July 31, 2020BLA761163 Tafasitamab-cxix
MONJUVI
Morphosys Us Inc
April 17, 2020NDA213736 Pemigatinib
PEMAZYRE
Incyte Corp
November 16, 2011NDA202192 Ruxolitinib
JAKAFI
Incyte Corp

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

No recall of these products (by NDC code) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →